Healthcare industries are facing an enormous flow of medical records due to the progression of information technology and the trend of digital transformation. Thus, medical information digitalization is a huge digital dataset that can be utilized to benefit healthcare systems and patients. While many studies focus on the application of the digitalized medical information in the healthcare field, only a few mentioned its resistance. The theoretical background depicts a comprehensive overview of medical information digitalization and the barriers in previous literature. This study emphasized the interaction of medical information digitalization barriers and applies the importance-resistance analysis model (IRA) to identify the resistant factors overcoming strategy. It also clarifies the pathway to eliminating the innovation resistance and reveals the interaction of medical information digitalization barriers. The acquisition, management, and application of medical information digitalization are the key foundation of medical technology innovation, digital transformation, and the application of artificial intelligence. This work can reduce the limitation of a narrow healthcare context. This study helps healthcare industries to clarify and solve barriers and realizes the innovation and application of medical information digitalization. In the long term, the results provide a basis for the future development direction of medical information digitalization and affect the medical industry.

The medical technology (Med-Tech) industry turnover has reached a record high, attracting a great deal of capital investment, while mergers and acquisitions continually increase. In order to move to a higher value-added segment, traditional Med-Tech manufacturers have to transform into digital smart manufacturers. This development trend promotes industrial operators of Med-Tech to consider how to strengthen professional competence, expand their market, and determine the future direction. This study proposed the value-driving forces of Med-Tech enterprise, based on five aspects: Professional competence (PC), operation management (OM), critical resources (CR), regulatory system (RS), and market expansion (ME). Then, the acquisition and importance analysis (AIA) and the network relation map (NRM) approaches were proposed and implemented to find an optimal pathway for a Med-Tech enterprise to implement digital transformation. Our findings suggest that Med-Tech enterprises should treat RS as the priority in transformation. Finally, based on small- and medium-sized Med-Tech enterprise scenarios, we propose four development strategies (direct acquisition, strategic alliance, maintenance status, and in-house development) should be decided in the digital transformation process.

Medical device development involves user safety, and it is governed by specific regulations. The failure of medical device developers to consider the influence of users, the environment, and related organizations on product development during the design and development process can result in added risks to the use of medical technologies. Although many studies have examined the medical device development process, there has been no systematic and comprehensive assessment of the key factors affecting medical device development. This research synthesized the value of medical device industry stakeholders’ experiences through a literature review and interviews with industry experts. Then, it establishes an FIA-NRM model to identify the key factors affecting medical device development and suggests appropriate pathways for improvement. Results indicate that the development of medical devices should begin with stabilizing organizational characteristics, followed by strengthening technical capability and use environment, and finally, consideration should be given to the user action of medical devices. The results provide medical device developers with optimal development pathways and resource allocation recommendations to support developers in developing medical device development strategies as well as ensuring the safety and effectiveness of the products for end users.